ICB&DD  Welcomes Congwu Du as a New Member  

Professor               Department of Biomedical  Engineering (read more)                                                                                                                                                                                                                                                                                            Now, ICB&DD has an expert in brain optical imaging!

Congratulations to Maurizio Del Poeta for being elected to the American Academy of Microbiology as Fellow

Professor                    Department of  Microbiology and Immunology has been elected to the American Academy of Microbiology  as a Fellow, based on his scientific achievements and contributions to the field of microbiology.

ICB&DD  Welcomes Janet Hearing and Patrick Hearing as New Members                             

Associate Professor Department of  Microbiology and Immunology (read more)

Professor                                                  Department of Microbiology and Immunology (read more)

 Now, ICB&DD has virology in its expertise!

Congratulations to Professor Iwao Ojima Elected to European Academy of Sciences

Professor Ojima will be honored at the induction ceremony of new members at EurASc’s Annual Symposium and Ceremony of Awards event this April at the Sorbonne University in Paris, France, which will be held virtually due to the COVID-19 pandemic. (Read more)

  More News

Dr. Iwao Ojima, Distinguished Professor and Director, ICB&DD 

Welcome to the Institute of Chemical Biology & Drug Discovery

The primary objective of ICB&DD is to establish a world-class “ Center of Excellence” in chemical biology and drug discovery at Stony Brook.  The rapid and impressive advancement of chemical biology in the last decades clearly demonstrated that solutions for vast majority of medical problems rely on the understanding of the molecular basis of diseases, therapeutic targets, drug actions, and drug resistance.  ICB&DD promotes highly productive interdisciplinary and multidisciplinary research bridging the West, East and South campuses as well as Brookhaven National Laboratory to attack major and significant biomedical problems to find solutions including the discovery of novel therapeutic drugs. ICB&DD significantly contributes to the advancement of a truly comprehensive biomedical research enterprise from molecular science to clinic at Stony Brook.